{
    "Trade/Device Name(s)": [
        "BIOEASY Multi-Drug Test Cup"
    ],
    "Submitter Information": "Shenzhen Bioeasy Biotechnology Co., Ltd.",
    "510(k) Number": "K182530",
    "Predicate Device Reference 510(k) Number(s)": [
        "K153050"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NFT",
        "NFW",
        "NFY",
        "NGG",
        "NGI",
        "NFV",
        "NGL",
        "PTH",
        "NGM",
        "PTG",
        "QAW",
        "QBF"
    ],
    "Summary Letter Date": "November 9, 2018",
    "Summary Letter Received Date": "September 14, 2018",
    "Submission Date": "September 9, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3870",
        "21 CFR 862.3250",
        "21 CFR 862.3610",
        "21 CFR 862.3640",
        "21 CFR 862.3170",
        "21 CFR 862.3650",
        "21 CFR 862.3150",
        "21 CFR 862.3650",
        "21 CFR 862.3620",
        "21 CFR 862.3910",
        "21 CFR 862.3700"
    ],
    "Regulation Name(s)": [
        "Amphetamine Test System",
        "Cannabinoids Test System",
        "Cocaine and Cocaine Metabolites Test System",
        "Methamphetamine Test System",
        "Morphine Test System",
        "Benzodiazepine Test System",
        "Opiate Test System",
        "Barbiturate Test System",
        "Opiate Test System",
        "Methadone Test System",
        "Tricyclic Antidepressant Drugs Test System",
        "Propoxyphene Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Oxazepam",
        "Cocaine",
        "Marijuana",
        "Methamphetamine",
        "Morphine",
        "Oxycodone",
        "Secobarbital",
        "Buprenorphine",
        "Methylenedioxy-methamphetamine",
        "Phencyclidine",
        "Methadone",
        "Nortriptyline",
        "d-Propoxyphene"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Urine cup"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Competitive binding",
        "Lateral flow",
        "Immunochromatographic assay"
    ],
    "Methodologies": [
        "Lateral flow immunoassay"
    ],
    "Submission Type(s)": [
        "Test",
        "Kit",
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for BIOEASY Multi-Drug Test Cup, a qualitative lateral flow immunoassay kit for simultaneous drug detection in urine",
    "Indications for Use Summary": "Qualitative and simultaneous detection of Amphetamine, Oxazepam, Cocaine, Marijuana, Methamphetamine, Morphine, Oxycodone, Secobarbital, Buprenorphine, Methylenedioxy-methamphetamine, Phencyclidine, Methadone, Nortriptyline, and d-Propoxyphene in human urine at specified cutoff concentrations; for in vitro diagnostic use only",
    "fda_folder": "Toxicology"
}